Royal Bank of Canada
MBX

Royal Bank of Canada’s MBX Biosciences MBX Stock Holding History

Royal Bank of Canada’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22K Sell
751
-781
-51% -$26.6K ﹤0.01% 5869
2025
Q4 		$49K Buy
1,532
+572
+60% +$13.9K ﹤0.01% 5572
2025
Q3 		$17K Sell
960
-338
-26% -$4.52K ﹤0.01% 6292
2025
Q2 		$15K Buy
1,298
+663
+104% +$6.75K ﹤0.01% 6370
2025
Q1 		$4K Sell
635
-198
-24% -$2.09K ﹤0.01% 6448
2024
Q4 		$16K Buy
+833
New +$17.8K ﹤0.01% 6212

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Royal Bank of Canada's MBX Position: Q1 2026 in Review

Royal Bank of Canada reduced its MBX Biosciences (MBX) stake by 51% in Q1 2026, selling an estimated $26.6K and leaving 751 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #5869.

Royal Bank of Canada first reported a position in MBX in Q4 2024 and has held it in 6 quarters since. The position peaked at $49K in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Royal Bank of Canada held 751 shares of MBX Biosciences worth $22K as of Q1 2026.
  • Royal Bank of Canada sold 781 MBX Biosciences shares in Q1 2026, an estimated $26.6K.
  • MBX Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5869 holding.
  • Royal Bank of Canada first reported a position in MBX Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Royal Bank of Canada's MBX Biosciences position peaked at $49K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.